Innate Pharma SA announces its financial results for the first half of 2008. Results for the first half of 2008 show a stable operational loss (4.7 million euros for the six-month period ended June 30, 2008 vs. 4.9 million euros in the same period last year) and a controlled consumption of cash from the operations (5.9 million euros for the six-month period ended June 30, 2008 vs. 4.5 million euros in the same period last year).